Assignee
SHANGHAI ACEMAB CORP LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
3 records- 0156US2024224963A9Recombinant genome, and non-human mammalian cell and production method therefor and use thereofSHANGHAI ACEMAB CORP LTD·Filed 2022·Application pending·0 cites
- 0245US2023242656A1Anti-bcma antibody, pharmaceutical composition of same, and applications thereofSHANGHAI ACEMAB CORP LTD·Filed 2021·Application pending·0 cites
- 0345US2024209104A1Anti-ox40 antibody, and pharmaceutical composition and application thereofSHANGHAI ACEMAB CORP LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI ACEMAB CORP LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →